ClinVar Miner

Submissions for variant NM_015340.4(LARS2):c.2203G>A (p.Val735Ile)

gnomAD frequency: 0.00045  dbSNP: rs141011840
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000594329 SCV000706604 uncertain significance not provided 2017-02-24 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV001449843 SCV001653145 likely benign not specified 2020-09-28 criteria provided, single submitter clinical testing The p.Val735Ile variant in LARS2 is classified as likely benign due to a lack of conservation across species. Twelve mammals (rhesus, baboon, crab-eating macaque, alpaca, dolphin, killer whale, David's myotis, microbat, big brown bat, opossum, Tasmanian devil, wallaby) carry a isoleucine (Ile) at this position despite high nearby amino acid conservation. It has also been identified in 0.1% (30/24904) of African chromosomes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BP4_Strong, BS1_Supporting.
GeneDx RCV000594329 SCV001785553 uncertain significance not provided 2022-02-09 criteria provided, single submitter clinical testing In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Invitae RCV000594329 SCV002166109 uncertain significance not provided 2022-06-15 criteria provided, single submitter clinical testing This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 735 of the LARS2 protein (p.Val735Ile). This variant is present in population databases (rs141011840, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with LARS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 500586). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.